US Bancorp DE Sells 2,236 Shares of Maximus, Inc. (NYSE:MMS)

US Bancorp DE trimmed its holdings in shares of Maximus, Inc. (NYSE:MMSGet Rating) by 20.3% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 8,797 shares of the health services provider’s stock after selling 2,236 shares during the period. US Bancorp DE’s holdings in Maximus were worth $510,000 at the end of the most recent reporting period.

A number of other hedge funds also recently made changes to their positions in the business. Victory Capital Management Inc. raised its stake in Maximus by 7.8% in the 2nd quarter. Victory Capital Management Inc. now owns 5,672,770 shares of the health services provider’s stock valued at $354,604,000 after acquiring an additional 408,672 shares during the period. Nordea Investment Management AB raised its stake in Maximus by 169.4% in the 2nd quarter. Nordea Investment Management AB now owns 235,241 shares of the health services provider’s stock valued at $14,458,000 after acquiring an additional 147,930 shares during the period. Assenagon Asset Management S.A. bought a new stake in Maximus in the 2nd quarter valued at about $9,233,000. The Manufacturers Life Insurance Company raised its stake in Maximus by 127.4% in the 1st quarter. The Manufacturers Life Insurance Company now owns 225,371 shares of the health services provider’s stock valued at $17,138,000 after acquiring an additional 126,257 shares during the period. Finally, Federated Hermes Inc. raised its stake in Maximus by 38.8% in the 1st quarter. Federated Hermes Inc. now owns 377,081 shares of the health services provider’s stock valued at $28,261,000 after acquiring an additional 105,322 shares during the period. 97.41% of the stock is currently owned by institutional investors.

Insider Activity

In other news, General Counsel David Francis sold 1,800 shares of the business’s stock in a transaction dated Wednesday, November 23rd. The stock was sold at an average price of $70.92, for a total transaction of $127,656.00. Following the completion of the transaction, the general counsel now owns 13,658 shares of the company’s stock, valued at $968,625.36. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other Maximus news, Director Raymond B. Ruddy acquired 5,730 shares of the business’s stock in a transaction dated Wednesday, December 7th. The stock was bought at an average price of $69.91 per share, with a total value of $400,584.30. Following the completion of the acquisition, the director now owns 109,030 shares of the company’s stock, valued at $7,622,287.30. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, General Counsel David Francis sold 1,800 shares of the business’s stock in a transaction dated Wednesday, November 23rd. The stock was sold at an average price of $70.92, for a total value of $127,656.00. Following the transaction, the general counsel now directly owns 13,658 shares of the company’s stock, valued at approximately $968,625.36. The disclosure for this sale can be found here. Company insiders own 1.90% of the company’s stock.

Maximus Trading Up 0.5 %

Shares of MMS opened at $72.38 on Monday. The business’s 50-day moving average price is $70.93 and its 200-day moving average price is $64.55. Maximus, Inc. has a twelve month low of $54.46 and a twelve month high of $79.78. The stock has a market cap of $4.40 billion, a PE ratio of 22.00 and a beta of 0.70. The company has a quick ratio of 1.33, a current ratio of 1.33 and a debt-to-equity ratio of 0.83.

Maximus (NYSE:MMSGet Rating) last announced its quarterly earnings results on Monday, November 21st. The health services provider reported $1.40 earnings per share for the quarter, beating the consensus estimate of $1.02 by $0.38. Maximus had a return on equity of 17.59% and a net margin of 4.40%. The firm had revenue of $1.18 billion for the quarter, compared to analysts’ expectations of $1.09 billion. On average, equities analysts forecast that Maximus, Inc. will post 3.87 EPS for the current fiscal year.

Maximus Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, February 28th. Stockholders of record on Wednesday, February 15th will be given a dividend of $0.28 per share. This represents a $1.12 annualized dividend and a dividend yield of 1.55%. The ex-dividend date of this dividend is Tuesday, February 14th. Maximus’s dividend payout ratio is presently 34.04%.

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on MMS. StockNews.com began coverage on Maximus in a research note on Wednesday, October 12th. They issued a “hold” rating on the stock. TheStreet upgraded Maximus from a “c+” rating to a “b-” rating in a research note on Thursday, December 8th.

Maximus Profile

(Get Rating)

MAXIMUS, Inc engages in the operation of government health and human services programs, and the provision of technology solutions to government. It operates through the following segments: U.S. Services, U.S. Federal Services, and Outside the U.S. The U.S. Services segment offers business process services (BPS), appeals and assessments, and related consulting work for U.S.

Featured Articles

Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maximus, Inc. (NYSE:MMSGet Rating).

Institutional Ownership by Quarter for Maximus (NYSE:MMS)

Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.